Login / Signup

Matching-adjusted indirect comparison of PFS and OS comparing ribociclib plus letrozole versus palbociclib plus letrozole as first-line treatment of HR+/HER2- advanced breast cancer.

Komal L JhaveriJoyce O'ShaughnessyPeter A FaschingSara M TolaneyDenise A YardleyVikash Kumar SharmaChandroday BiswasAstrid ThuerigenPurnima PathakHope S Rugo
Published in: Therapeutic advances in medical oncology (2023)
NCT01958021; https://www.clinicaltrials.gov/study/NCT01958021 (MONALEESA-2) and NCT01740427; https://clinicaltrials.gov/study/NCT01740427 (PALOMA-2).
Keyphrases
  • type diabetes
  • adipose tissue
  • skeletal muscle
  • clinical evaluation